Stock Yearly Return 2018
Start date: 01/02/2018
End date: 12/31/2018
Start price/share: $18.14
End price/share: $13.36
Dividends collected/share: $0.00
Total return: -26.35%
CORT Average Annual Return: -26.50%
Starting investment: $10,000.00
Ending investment: $7,365.00
Years: 0.99


CORT average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare CORT average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into CORT


Also see:
CORT stock yearly return 2019
CORT stock yearly return 2020
CORT YTD return
CORT average annual return 10 years
Corcept Therapeutics is a commercial-stage company engaged in the discovery and development of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the steroid hormone cortisol. Co. has marketed the cortisol modulator Korlym in the U.S. for the treatment of patients with a form of hypercortisolism known as endogenous Cushing's syndrome. Co.'s primary compounds have entered the clinic as potential treatments for serious disorders, including Cushing's syndrome, solid tumors (such as ovarian cancer, castration-resistant prostate cancer and adrenocortical cancer with cortisol excess), antipsychotic medications and non-alcoholic steatohepatitis. The CORT stock yearly return is shown above.

The yearly return on the CORT stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2018 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the CORT annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for CORT:
CORT SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Corcept Therapeutics (CORT) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

COT Average Annual Return
CPIX Average Annual Return
CPRX Average Annual Return
CRBP Average Annual Return
CRIS Average Annual Return
CRL Average Annual Return
CRMD Average Annual Return
CRTX Average Annual Return
CRVL Average Annual Return
CRVS Average Annual Return
More Healthcare companies »

 

CORT Stock Yearly Return 2018 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.